Albert Cha insider trades: Frazier Life Sciences Acquisition Corp. II (FLSC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Albert reports to the SEC
and 4 more companies
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | FLSC | ↑ Buy | 300,000 | $10.00 | $3.0M | By Frazier Life Sciences Holdings II LLC | Oct 15, 2026 (0d) |
| Sep 11, 2023 | KALV | ↓ Sell | 18,000 | $10.50 | $189K | Direct | Sep 13, 2023 (2d) |
| Oct 30, 2020 | KALV | ↑ Buy | 115,686 | $17.24 | $2.0M | By Vivo Opportunity Fund, L.P. | Nov 3, 2020 (4d) |
| Jul 29, 2019 | KALV | ↑ Buy | 46,672 | $16.99 | $793K | By Vivo Opportunity Fund, L.P. | Jul 30, 2019 (1d) |
| Jul 29, 2019 | KALV | ↑ Buy | 9,695 | $16.99 | $165K | By Vivo Capital Fund IX, L.P. | Jul 30, 2019 (1d) |
| Jul 19, 2019 | KALV | ↑ Buy | 50,740 | $17.82 | $904K | By Vivo Opportunity Fund, L.P. | Jul 19, 2019 (0d) |
| Jul 19, 2019 | KALV | ↑ Buy | 10,540 | $17.66 | $186K | By Vivo Capital Fund IX, L.P. | Jul 19, 2019 (0d) |
| Sep 10, 2018 | KALV | ↑ Buy | 1,058,824 | $17.00 | $18.0M | Indirect | Sep 12, 2018 (2d) |
| Jan 25, 2018 | MNLO | ↑ Buy | 258,432 | $17.00 | $4.4M | By Vivo Capital Fund VIII, L.P. | Jan 29, 2018 (4d) |
| Jan 25, 2018 | MNLO | ↑ Buy | 35,686 | $17.00 | $607K | By Vivo Capital Surplus Fund III, L.P. | Jan 29, 2018 (4d) |
| May 9, 2017 | BHVN | ↑ Buy | 470,000 | $17.00 | $8.0M | Indirect | May 9, 2017 (0d) |
| Oct 13, 2015 | ACRS | ↑ Buy | 454,545 | $11.00 | $5.0M | By funds | Oct 13, 2015 (0d) |
| Oct 7, 2015 | ACRS | ↑ Buy | 13,352 | $11.00 | $147K | By funds | Oct 9, 2015 (2d) |
| Jul 21, 2015 | DNAI | ↑ Buy | 215,307 | $17.00 | $3.7M | By Vivo Ventures Fund VII, L.P. | Jul 21, 2015 (0d) |
| Jul 21, 2015 | DNAI | ↑ Buy | 4,693 | $17.00 | $80K | By Vivo Ventures VII Affiliates Fund, L. | Jul 21, 2015 (0d) |
| Apr 14, 2015 | CBYL | ↑ Buy | 1,012,500 | $5.00 | $5.1M | Indirect | Apr 14, 2015 (0d) |
| Feb 12, 2008 | BIOD | ↓ Sell | 132,000 | $15.50 | $2.0M | Indirect | Feb 14, 2008 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FLSC insiders
Open-market trades in the last 12 months
About Albert Cha's insider trades
Albert Cha is Chief Executive Officer at Frazier Life Sciences Acquisition Corp. II (FLSC). Since Feb 12, 2008, Albert has reported 15 open-market purchases worth $52.0M and 2 sales worth $2.2M on SEC Form 4. In the last 12 months: 1 buy ($3.0M).
Their filings also include grants and awards (12 filings), conversions (8 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FLSC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.